SCHEMBL3972862

SCHEMBL3972862

CC(C)N(CCCc1ccc2ccccc2c1)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.60
SIGMAR1 Q99720 4/20 0.59
CYP1A2 P05177 2/20 0.47
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
CYP2A6 P11509 1/20 0.45
MC4R P32245 2/20 0.43
MC5R P33032 2/20 0.43
MC3R P41968 2/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3971600 0.85 SIGMAR1 (0.52) BCHESIGMAR1CYP1A2CYP2A6MC4R
SCHEMBL15701722 0.82 BCHE (0.58) BCHESIGMAR1CYP1A2OPRD1OPRK1
SCHEMBL9520781 0.79 SIGMAR1 (0.62) BCHESIGMAR1CYP1A2CYP2A6HTR2A
SCHEMBL8082126 0.79 AOC3 (0.47) BCHESIGMAR1CYP1A2OPRD1OPRK1
SCHEMBL8075773 0.77 OPRK1 (0.46) BCHEOPRD1OPRK1SLC6A2SLC6A4
SCHEMBL29286752 0.75 BCHE (1.00) BCHESIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL14024617 0.75 SIGMAR1 (0.54) BCHESIGMAR1CYP1A2OPRD1OPRK1
SCHEMBL9523589 0.75 SIGMAR1 (0.55) BCHESIGMAR1CYP1A2CYP2A6HTR2A
SCHEMBL12153268 0.74 BCHE (0.56) BCHESIGMAR1CYP1A2CYP2A6HTR2A
SCHEMBL13025061 0.74 AOC3 (0.48) CYP1A2OPRD1OPRK1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801476-A2 METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS Kartos Therapeutics, Inc. (US) 2021-04-14 EP disclosed
WO-2010104406-A1 PRODRUG FORMS OF KINASE INHIBITORS AND THEIR USE IN THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2010-09-16 WO disclosed
WO-2009051661-A2 SUBSTITUTED ARYL ALKYLAMINO-OXY-ANALOGS AND USES THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2009-04-23 WO disclosed